Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer

SIMPLE SUMMARY: The rational, benefits and limits of therapeutic drug monitoring as a routine practice are discussed for the seven tyrosine kinase inhibitor compounds currently used to treat advanced renal cell carcinoma. ABSTRACT: Seven tyrosine kinase inhibitor compounds with anti-angiogenic prope...

Descripción completa

Detalles Bibliográficos
Autores principales: Puisset, Florent, Mseddi, Mourad, Mourey, Loïc, Pouessel, Damien, Blanchet, Benoit, Chatelut, Etienne, Chevreau, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818258/
https://www.ncbi.nlm.nih.gov/pubmed/36612311
http://dx.doi.org/10.3390/cancers15010313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818258/
https://www.ncbi.nlm.nih.gov/pubmed/36612311
http://dx.doi.org/10.3390/cancers15010313

Ejemplares similares